4.7 Review

Adenosine and autism: A spectrum of opportunities

期刊

NEUROPHARMACOLOGY
卷 68, 期 -, 页码 116-121

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2012.08.013

关键词

Adenosine; Anxiety; Autism; ATP; Ketogenic diet; Metabolism

资金

  1. National Institutes of Health from the National Institute of Neurological Disorders and Stroke (NINDS) [NS065957, NS066932]
  2. National Science Foundation [IOS-0843585]
  3. Division Of Integrative Organismal Systems
  4. Direct For Biological Sciences [843585] Funding Source: National Science Foundation

向作者/读者索取更多资源

In rodents, insufficient adenosine produces behavioral and physiological symptoms consistent with several comorbidities of autism. In rodents and humans, stimuli postulated to increase adenosine can ameliorate these comorbidities. Because adenosine is a broad homeostatic regulator of cell function and nervous system activity, increasing adenosine's influence might be a new therapeutic target for autism with multiple beneficial effects. This article is part of the Special Issue entitled 'Neurodevelopmental Disorders'. (c) 2012 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据